Chronic Kidney Disease Trial, Recruiting (NCT05642156)

Chronic Kidney Disease Trial, Recruiting NCT05642156 Sponsor: Medical University of Graz Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05642156 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be willing and able to give written agreement to take part in the study
You must be at least 18 years old
You must have end-stage kidney failure and currently be receiving hemodialysis (a type of dialysis that cleans your blood using a machine)
Your body weight must have been stable for at least one month
Between your shorter dialysis sessions, you must be retaining more than 2 litres of fluid

Who may not be able to join:

People who are not able or willing to give written consent to take part
People who have a pacemaker or another implanted medical device that may interfere with the study requirements
People currently receiving a type of dialysis called hemodiafiltration
People whose dialysis uses a specific type of filter membrane called a medium cut-off membrane (such as Theranova by Baxter)
People who regularly have dangerously high potassium levels in their blood after their shorter dialysis sessions, which take more than 2 hours of dialysis to bring under control (confirm with trial site)
Women who are of childbearing age and are not currently using contraception

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +43316385

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05642156

Sponsor: Medical University of Graz

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: +43316385

More information: https://clinicaltrials.gov/study/NCT05642156

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be willing and able to give written agreement to take part in the study
You must be at least 18 years old
You must have end-stage kidney failure and currently be receiving hemodialysis (a type of dialysis that cleans your blood using a machine)
Your body weight must have been stable for at least one month
Between your shorter dialysis sessions, you must be retaining more than 2 litres of fluid

Who may not be able to join:

People who are not able or willing to give written consent to take part
People who have a pacemaker or another implanted medical device that may interfere with the study requirements
People currently receiving a type of dialysis called hemodiafiltration
People whose dialysis uses a specific type of filter membrane called a medium cut-off membrane (such as Theranova by Baxter)
People who regularly have dangerously high potassium levels in their blood after their shorter dialysis sessions, which take more than 2 hours of dialysis to bring under control (confirm with trial site)
Women who are of childbearing age and are not currently using contraception

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Graz

Registry

ClinicalTrials.gov

Start date

2 November 2022

Est. completion

31 December 2025

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Total peripheral resistance index (TPRI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov